Ginkgo Bioworks Holdings (DNA) Capital Expenditures Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 31.13% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 291.15% |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -11.88% |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | -31.43% |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 20.00% |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 6,792.11% |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 712.82% |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 96.82% |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,792.11% |
| Mar 31, 2026 | -74.64% |
| Dec 31, 2025 | -99.96% |
| Jun 30, 2025 | -99.86% |
| Mar 31, 2025 | 13.59% |
| Dec 31, 2024 | 297.85% |
| Sep 30, 2024 | 244.42% |
| Jun 30, 2024 | 99.75% |
| Mar 31, 2024 | -65.49% |
| Dec 31, 2023 | -86.56% |
| Sep 30, 2023 | -67.48% |
| Jun 30, 2023 | 41.37% |
| Mar 31, 2023 | 443.04% |
| Dec 31, 2022 | 401.47% |
| Sep 30, 2022 | 147.76% |
| Jun 30, 2022 | -60.17% |
| Mar 31, 2022 | -83.68% |
| Dec 31, 2021 | -73.66% |